Cholesterol lowering and inhibition of sterol absorption by Lactobacillus reuteri NCIMB 30242: a randomized controlled trial (Q84993350)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22990854%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

title

Cholesterol lowering and inhibition of sterol absorption by Lactobacillus reuteri NCIMB 30242: a randomized controlled trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22990854%20AND%20SRC:MED&resulttype=core&format=json

randomized controlled trial

13 February 2020

main subject

1 reference

inferred from title

Lactobacillus reuteri

object named as

Lactobacillus reuteri

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22990854%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

M L Jones

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22990854%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

C J Martoni

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22990854%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

publication date

19 September 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22990854%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Nutrition

13 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22990854%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

volume

66

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22990854%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

1234-1241

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22990854%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22990854%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/ejcn.2012.126

13 February 2020

exact match

0 references

cites work

Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.126

7 January 2021

Evaluating novel cardiovascular risk factors: can we better predict heart attacks?

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.126

7 January 2021

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.126

7 January 2021

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.126

7 January 2021

AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.126

7 January 2021

Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome.

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.126

7 January 2021

Intestinal Bile Acids and Cholesterol Absorption in the Germfree Rat

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.126

7 January 2021

Cholesterol-lowering probiotics as potential biotherapeutics for metabolic diseases

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.126

7 January 2021

Bifidobacterium animalis strain DN-173 010 hydrolyses bile salts in the gastrointestinal tract of pigs

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.126

7 January 2021

Cholesterol lowering in pigs through enhanced bacterial bile salt hydrolase activity.

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.126

7 January 2021

Effect of 8 week intake of probiotic milk products on risk factors for cardiovascular diseases

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.126

7 January 2021

Evaluation of the effects of a new fermented milk product (Gaio) on primary hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.126

7 January 2021

Cholesterol-lowering efficacy of a microencapsulated bile salt hydrolase-active Lactobacillus reuteri NCIMB 30242 yoghurt formulation in hypercholesterolaemic adults

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.126

7 January 2021

Effects of a milk product, fermented by Lactobacillus acidophilus and with fructo-oligosaccharides added, on blood lipids in male volunteers.

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.126

7 January 2021

Lactobacillus effects on cholesterol: in vitro and in vivo results

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.126

7 January 2021

A double-blind placebo-controlled study of the effects of Lactobacillus acidophilus on plasma lipids

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.126

7 January 2021

Probiotic capsules do not lower plasma lipids in young women and men.

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.126

7 January 2021

Yoghurt enriched with Lactobacillus acidophilus does not lower blood lipids in healthy men and women with normal to borderline high serum cholesterol levels

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.126

7 January 2021

Lactobacillus gasseri [corrected] CHO-220 and inulin reduced plasma total cholesterol and low-density lipoprotein cholesterol via alteration of lipid transporters.

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.126

7 January 2021

Evaluation of safety and tolerance of microencapsulated Lactobacillus reuteri NCIMB 30242 in a yogurt formulation: a randomized, placebo-controlled, double-blind study

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.126

7 January 2021

Evaluation of clinical safety and tolerance of a Lactobacillus reuteri NCIMB 30242 supplement capsule: a randomized control trial

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.126

7 January 2021

Rapid quantification of bile acids and their conjugates in serum by liquid chromatography–tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.126

7 January 2021

Influence of consumption of probiotics on the plasma lipid profile: a meta-analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.126

7 January 2021

Effects of consumption of probiotics and prebiotics on serum lipid levels in humans

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.126

7 January 2021

Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.126

7 January 2021

The role of serum non-cholesterol sterols as surrogate markers of absolute cholesterol synthesis and absorption

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.126

7 January 2021

Inhibition of intestinal cholesterol absorption by ezetimibe in humans

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.126

7 January 2021

Baseline cholesterol absorption and the response to ezetimibe/simvastatin therapy: a post-hoc analysis of the ENHANCE trial

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.126

7 January 2021

Synthesis and absorption markers of cholesterol in serum and lipoproteins during a large dose of statin treatment

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.126

7 January 2021

Plasma concentrations of plant sterols: physiology and relationship with coronary heart disease.

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.126

7 January 2021

Hypocholesterolemic effects of Lactobacillus plantarum KCTC3928 by increased bile acid excretion in C57BL/6 mice

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.126

7 January 2021

Targeting bile-acid signalling for metabolic diseases

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.126

7 January 2021

Bile acids: regulation of synthesis

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.126

7 January 2021

Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.126

7 January 2021

The liver X receptor gene team: potential new players in atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.126

7 January 2021

Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.126

7 January 2021

Bile acids stimulate ATP hydrolysis in the purified cholesterol transporter ABCG5/G8.

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.126

7 January 2021

Lactobacillus rhamnosus BFE 5264 and Lactobacillus plantarum NR74 Promote Cholesterol Excretion Through the Up-Regulation of ABCG5/8 in Caco-2 Cells

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.126

7 January 2021

The probiotic Lactobacillus acidophilus reduces cholesterol absorption through the down-regulation of Niemann-Pick C1-like 1 in Caco-2 cells

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.126

7 January 2021

Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.126

7 January 2021

Fibrinogen and associated risk factors in a high-risk population: urban Indigenous Australians, the DRUID Study

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.126

7 January 2021

The influence of probiotic supplementation on gut permeability in patients with metabolic syndrome: an open label, randomized pilot study.

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.126

7 January 2021

C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.126

7 January 2021

Genetic variation, C-reactive protein levels, and incidence of diabetes.

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.126

7 January 2021

C-reactive protein and the risk of developing hypertension

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.126

7 January 2021

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.126

7 January 2021

Common variants in the CRP gene in relation to longevity and cause-specific mortality in older adults: the Cardiovascular Health Study

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.126

7 January 2021

C-reactive protein and the risk of incident colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.126

7 January 2021

Regulated de novo biosynthesis of fibrinogen in extrahepatic epithelial cells in response to inflammation

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.126

7 January 2021

Evidence for anti-inflammatory activity of statins and PPARalpha activators in human C-reactive protein transgenic mice in vivo and in cultured human hepatocytes in vitro

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.126

7 January 2021

Beta-blockers are associated with lower C-reactive protein concentrations in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.126

7 January 2021

Identifiers

DOI

10.1038/EJCN.2012.126

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22990854%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

13 February 2020

0 references

1 reference